FDA Should Get Industry Input Before Issuing Draft Guidances - PhRMA
Executive Summary
FDA should get input from industry before the release of draft guidances, the Pharmaceutical Research & Manufacturers of America suggests in comments to FDA on the implementation of good guidance practice provisions included in the FDA Modernization Act.
You may also be interested in...
PhRMA Recruits BIO Technical Affairs Staffer Goldhammer For Reg Affairs
Alan Goldhammer, PhD, a sixteen-year veteran of representing the biotechnology industry in Washington, has moved to the regulatory affairs staff of the Pharmaceutical Research & Manufacturers of America.
PhRMA Recruits BIO Technical Affairs Staffer Goldhammer For Reg Affairs
Alan Goldhammer, PhD, a sixteen-year veteran of representing the biotechnology industry in Washington, has moved to the regulatory affairs staff of the Pharmaceutical Research & Manufacturers of America.
Industry Active Role In Guidance Development Urged By Wyeth's Burlington
Regulated industry should take a more aggressive approach to writing guidances, Wyeth-Ayerst Senior VP-Global Regulatory Affairs Bruce Burlington, PhD, told a Parenteral Drugs Association/FDA joint conference Sept. 29 in Bethesda, Md.